Early Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple Myeloma – Targeted Oncology
NBCNews.com |
Early Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple Myeloma
Targeted Oncology Treatment with chimeric antigen receptor (CAR) T cells that target B-cell maturation protein (BMCA) achieved clinical remissions in 33 out of 35 patients (94%) with relapsed or refractory multiple myeloma in early results from a Chinese study presented … CAR T-Cell Therapy Effective in Multiple Myeloma CAR–T Cancer Approach Has Surprising Success in Multiple Myeloma CAR T- Cell Therapy Could Be A Promising Treatment For Multiple Myeloma Cancer |
